• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Lyra Therapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 391K and EPS of USD -15.3982
04:00
Lyra Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 25K (forecast USD 154.25K), actual EPS USD -3.3849 (forecast USD -5.255)
04:00
Oct14
Hanbury Brown's Rating and Target Price for Lyra Therapeutics
11:22
Oct6
Hanbury Brown Rates Healthcare Sector Stocks
19:46
Aug13
Lyra Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 183K (forecast USD 181.25K), actual EPS USD -5.5144 (forecast USD -5.5266)
03:00
Lyra Therapeutics released FY2025 Semi-Annual Earnings on August 12 EST, with actual revenue of USD 366 K and EPS of USD -12.0001
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 25 K, Net Income -5.984 M, EPS -3.3849

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 183 K, Net Income -7.437 M, EPS -5.5144

May28
Reverse Stock Split(EST)

1-for-50 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More